SHEN211 tablets

DRUG2 trials

Sponsors

JKT Biopharma Co., Ltd.

Conditions

COVID-19Phase 1

Phase 1

The Safety, Tolerability, Pharmacokinetics and Food Effects of SHEN211 Tablet in Healthy Subjects

JKT Biopharma Co., Ltd.Phase 1

Start: 2023-12-14End: 2024-04-30Target: 76Updated: 2024-01-22

Phase 2

SHEN211 Tablets for the Treatment of Mild and Moderate Novel Corona Virus Infections (COVID-19)

Not yet recruitingNCT06288893

JKT Biopharma Co., Ltd.COVID-19

Start: 2024-04-01End: 2025-01-01Target: 30Updated: 2024-03-04